Lupeng Ye
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lupeng Ye has a total of 177 co-authors. Here are the top co-authors by number of shared publications:
- Sidi Chen
Department of Genetics, Yale University School of Medicine, New haven, CT, USA
86 shared publications - Guangchuan Wang
Chinese Academy of Sciences Center for Excellence in Molecular Cell Science
80 shared publications - Youssef Errami
Department of Surgery, Tulane University School of Medicine, New Orleans, LA 70112, USA
80 shared publications - Jonathan Joon-Young Park
Department of Dermatology, Northwestern University Feinberg School of Medicine , Chicago, IL
78 shared publications - Quanjun Yang
Department of Pharmacy, Shanghai Sixth People's Hospital Affiliated Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China
76 shared publications - Arianny Acosta
Department of Genetics, Yale University School of Medicine, New Haven, Connecticut
74 shared publications
Latest Publications
- Open Access
- 16 November 2026
- Published by Springer Nature in Nature Biotechnology
A CD7-targeted AAV variant enables efficient T and NK cell engineering in vivo
Adeno-associated virus (AAV) vectors have been applied for precise genome engineering in human T cells but poor tropism restricts their efficiency and translational potential. Here, through directed evolution of the AAV6 capsid in primary human T cells, we identified a family of variants containing an APR motif at residues 455–457. The lead candidate, AAV.APR31, enabled robust transduction of primary T and NK cells at nearly 100–1,000-fold lower doses than AAV6 and outperformed the human T cell-tropic capsid AAV-hT7. CRISPR screening identified CD7 as a lineage-specific entry enhancer alongside the canonical AAVR pathway and structural analysis suggested that the APR motif facilitates CD7 engagement. Unlike existing delivery systems confined to one engineering mode, AAV.APR31 enabled transient transgene delivery, site-specific knock-in and transposon integration in human T and NK cells, generating CAR-T cells functionally equivalent to lentiviral vector-manufactured products. Systemic administration of AAV.APR31-generated CAR-T cells in vivo resulted in potent tumor control in hematologic and solid tumor mouse models.
- 16 November 2026
- Published by Springer Nature in Nature Biotechnology
Open AccessA CD7-targeted AAV variant enables efficient T and NK cell engineering in vivo
Adeno-associated virus (AAV) vectors have been applied for precise genome engineering in human T cells but poor tropism restricts their efficiency and translational potential. Here, through directed evolution of the AAV6 capsid in primary human T cells, we identified a family of variants containing an APR motif at residues 455–457. The lead candidate, AAV.APR31, enabled robust transduction of primary T and NK cells at nearly 100–1,000-fold lower doses than AAV6 and outperformed the human T cell-tropic capsid AAV-hT7. CRISPR screening identified CD7 as a lineage-specific entry enhancer alongside the canonical AAVR pathway and structural analysis suggested that the APR motif facilitates CD7 engagement. Unlike existing delivery systems confined to one engineering mode, AAV.APR31 enabled transient transgene delivery, site-specific knock-in and transposon integration in human T and NK cells, generating CAR-T cells functionally equivalent to lentiviral vector-manufactured products. Systemic administration of AAV.APR31-generated CAR-T cells in vivo resulted in potent tumor control in hematologic and solid tumor mouse models.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S3 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S3 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S8 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S8 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S8 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S8 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S7 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S7 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S1 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S1 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S2 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S2 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S4 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S4 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S5 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S5 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S6 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S6 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function